1
/
of
1
Alpha BioMed
FOXO4-DRI (15mg)
FOXO4-DRI (15mg)
A provider account is required to view prices and to place orders. Click the button below to submit your application!
Have an account? Login here.
- FOXO4-DRI (15mg) is a synthetic peptide designed to selectively disrupt the interaction between FOXO4 and p53, thereby enabling investigation into senescence-associated pathways and cellular clearance mechanisms in non-clinical models.
- This compound functions by modulating key transcriptional pathways involved in cellular stress response and apoptosis, making it an innovative tool for studies focused on senescence, cell cycle arrest, and tissue remodeling in research environments.
- FOXO4-DRI plays a significant role in experimental models exploring the regulation of cellular homeostasis through selective targeting of senescent phenotypes. Research has indicated its potential to modulate inflammation-related pathways and support studies in age-related degeneration and tissue maintenance.
- Beyond its observed senescence-targeting effects in vitro, FOXO4-DRI may be utilized in ongoing research into mitochondrial signaling and cellular stress adaptation mechanisms.
- FOXO4-DRI (15mg) offers a valuable compound for exploring experimental models related to longevity, tissue regeneration, and age-associated disease processes, making it an important asset for advanced biomedical research.
